| Bioactivity | PHD-IN-2 (Compound 91) is a PHD antagonist (IC50: < 5 nM). PHD-IN-2 induces erythropoietin synthesis in HEP3B cells (EC50: <2.5 μM). PHD-IN-2 can be used for research of cardiovascular disorders, metabolic disorders, hematological disorders, pulmonary disorders, kidney disorders, liver disorders, wound healing disorders, and cancer[1]. |
| Name | PHD-IN-2 |
| CAS | 2924182-42-1 |
| Formula | C26H27N7O4 |
| Molar Mass | 501.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiao DING, et al. Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereof. Patent. US20230192723A1. |
PHD-IN-2
CAS: 2924182-42-1 F: C26H27N7O4 W: 501.54
PHD-IN-2 (Compound 91) is a PHD antagonist (IC50: < 5 nM). PHD-IN-2 induces erythropoietin synthesis in HEP3B cells (EC5
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.